Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-05-21

FDA Approved: DALFAMPRIDINE — Original Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved Sun Pharmaceutical's generic dalfampridine (Dalfampridine) for improving walking in adults with multiple sclerosis through an Original Abbreviated …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dalfampridine (dalfampridine)

Snippet

ORIG AP for DALFAMPRIDINE (DALFAMPRIDINE)